Ascentage Pharma Group International (AAPG) Enterprise Value (2022 - 2025)
Ascentage Pharma Group International posted quarterly Enterprise Value of -$168.6 million for Q4 2025, down 35.6% year-on-year from -$261.8 million in Q4 2024, and down 35.6% on a QoQ basis from -$124.3 million in Q4 2024.
Ascentage Pharma Group International (AAPG) has 4 years of Enterprise Value data on file, last reported at -$168.6 million in Q4 2025.
- For the quarter ending Q4 2025, Enterprise Value fell 35.6% year-over-year to -$168.6 million; the trailing twelve-month figure through Dec 2025 stood at -$168.6 million (down 35.6% YoY), and the FY2025 full-year result was -$166.4 million, down 33.83% from the prior year.
- Enterprise Value for Q4 2025 stood at -$168.6 million, down from -$124.3 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$124.3 million in Q4 2024 and bottomed at -$189.2 million in Q4 2022.
- The 4-year median for Enterprise Value is -$156.4 million (2025), against an average of -$156.6 million.
- The widest annual swing landed in 2023, when Enterprise Value gained 23.8%; it then sank 35.6% in 2025.
- A 4-year view of Enterprise Value shows it stood at -$189.2 million in 2022, then gained by 23.8% to -$144.2 million in 2023, then climbed by 13.76% to -$124.3 million in 2024, then sank by 35.6% to -$168.6 million in 2025.
- The last three Enterprise Value figures came in at -$168.6 million (Q4 2025), -$124.3 million (Q4 2024), and -$144.2 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | -901.90 Mn |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | -8.75 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | -18.44 Mn |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Ascentage Pharma Group International | 1.11 Bn | 937.28 Mn | - | -168.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -168.60 Mn |
| Dec 31, 2024 | -124.33 Mn |
| Dec 31, 2023 | -144.17 Mn |
| Dec 31, 2022 | -189.20 Mn |